MediPal Holdings Corporation
7459
Classement en actions
#4251
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Prix de l'action
$20.55
Capitalisation boursière
$3.73B
Changement (1 jour)
0.77%
Changement (1 an)
22.26%
Pays
JP
Échange MediPal Holdings Corporation (7459)
Catégorie
Healthcare
Marge opérationnelle de MediPal Holdings Corporation (7459)
Marge opérationnelle au October 2026 TTM : 1.36%
Selon les derniers rapports financiers et le cours de l'action de MediPal Holdings Corporation, la marge opérationnelle actuelle (TTM) est de 1.36%. À la fin de 2024, elle était de 1.33%.
Historique de la marge opérationnelle pour MediPal Holdings Corporation de 2005 à 2026
Marge opérationnelle à la fin de chaque année
| Année | Marge opérationnelle | Changez |
|---|---|---|
| 2026 (TTM) | 1.36% | -9.93% |
| 2025 | 1.51% | 13.53% |
| 2024 | 1.33% | -8.90% |
| 2023 | 1.46% | 5.04% |
| 2022 | 1.39% | 15.83% |
| 2021 | 1.20% | -26.38% |
| 2020 | 1.63% | 3.82% |
| 2019 | 1.57% | 11.35% |
| 2018 | 1.41% | 9.30% |
| 2017 | 1.29% | -7.86% |
| 2016 | 1.40% | 22.81% |
| 2015 | 1.14% | -3.39% |
| 2014 | 1.18% | 16.83% |
| 2013 | 1.01% | 32.89% |
| 2012 | 0.76% | 49.02% |
| 2011 | 0.51% | -29.17% |
| 2010 | 0.72% | 30.91% |
| 2009 | 0.55% | -55.65% |
| 2008 | 1.24% | -3.13% |
| 2007 | 1.28% | 19.63% |
| 2006 | 1.07% | 62.12% |
| 2005 | 0.66% | 0.00% |
Marge opérationnelle pour des entreprises similaires ou concurrentes
| Entreprise | Marge opérationnelle | Différence de Marge Opérationnelle | Pays |
|---|---|---|---|
| 1.62% | -98.81% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.24% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -93.23% |
AU
|
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.